C/A 0001620704 XXXXXXXX 020-34208 LIVE false false false false Amendment to add 2023 Audited financials, and increase the raise limit to $5,000,000. MED-X, INC. Corporation NV 02-24-2014 8236 REMMET AVE. CANOGA PARK CA 91304 https://medx-rx.com N DEALMAKER SECURITIES LLC 0001872856 008-70756 000315324 The Company is offering securities under Regulation CF, through Intermediary. Intermediary will receive cash compensation equal to 8.5% of the value of the securities sold through Regulation CF, fixed fees of $32,500 and a monthly fee of $2,000. $0 Common Stock 1666666 3.00000 4998.00 Y Other At Company's discretion 4999998.00 05-27-2025 17.00 1345328.00 2102959.00 65747.00 209472.00 50105.00 65373.00 520291.00 548331.00 0.00 0.00 1894784.00 1852775.00 1641617.00 1570977.00 0.00 0.00 6478496.00 7338431.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY A0 A1 A2 A3 A4 A5 A6 A7 A8 A9 B0 Z4 MED-X, INC. /s/ Matthew Mills Chief Executive Officer /s/ Matthew Mills Chief Executive Officer 09-26-2024